What is Artivion's cash & equivalents?

Artivion (AORT) reported cash & equivalents of $55.76M in Q1 2026.

How has Artivion's cash & equivalents changed year-over-year?

Artivion's cash & equivalents increased by 47.9% year-over-year, from $37.69M to $55.76M.

What is the long-term trend for Artivion's cash & equivalents?

Over 5 years (2020 to 2025), Artivion's cash & equivalents has grown at a 0.9% compound annual growth rate (CAGR), from $61.96M to $64.91M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Artivion AORT Cash & Equivalents

Cash & Equivalents at other companies

AbbottABT

$6.8B+4.1%

Edwards LifesciencesEW

$2.45B-22.3%

LeMaitre VascularLMAT

$26.85M+6.0%

MedtronicMDT

$1.95B-12.1%

ITG

Integer HoldingsITGR

$8.12M-74.4%

Merit Medical SystemsMMSI

$488.08M+23.4%

Other financials

Income statement

See full

Revenue$116.3M+17.5%

Gross profit$75.4M+18.7%

Operating income$5.8M+170%

Net income$1.4M+381%

EPS (diluted)$0.03+400%

Balance sheet

See full

Total debt$258.2M-28.8%

Total equity$450.5M+53.1%

Total assets$883.2M+11.6%

Cash flow

See full

Operating cash flow$1.2M+107%

CapEx$8.0M+120%

Free cash flow-$6.8M+66.7%

Valuation

See full

Market cap$1.07B-24.8%

Enterprise value$1.27B-27.2%

P/E91.5×—

P/S2.3×-1.3×

Profitability

See full

Gross margin64.6%+0.6pp

Operating margin8.2%+4.1pp

Net margin2.5%+1.5pp

FCF margin-0.1%-2.5pp

Returns & leverage

See full

Return on equity3.1%+1.8pp

Debt / equity0.6×-0.7×

Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artivion's cash & equivalents?: Artivion (AORT) reported cash & equivalents of $55.76M in Q1 2026.
How has Artivion's cash & equivalents changed year-over-year?: Artivion's cash & equivalents increased by 47.9% year-over-year, from $37.69M to $55.76M.
What is the long-term trend for Artivion's cash & equivalents?: Over 5 years (2020 to 2025), Artivion's cash & equivalents has grown at a 0.9% compound annual growth rate (CAGR), from $61.96M to $64.91M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.